Filing Details

Accession Number:
0001225208-17-014482
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-01 19:37:17
Reporting Period:
2017-08-31
Accepted Time:
2017-09-01 18:37:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
78003 Pfizer Inc PFE Pharmaceutical Preparations (2834) 135315170
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1194004 A Frank Damelio Pfizer Inc.-Corp. Secretary
235 East 42Nd St.
New York NY 10017
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-08-31 94,409 $34.00 337,389 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,925 Indirect By Rule 16b-3 Plan
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2017.